key: cord-1007689-vjwglx9f
authors: Fabiani, Laura; Mazzaracchio, Vincenzo; Moscone, Danila; Fillo, Silvia; De Santis, Riccardo; Monte, Anella; Amatore, Donatella; Lista, Florigio; Arduini, Fabiana
title: Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva
date: 2021-12-23
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2021.113909
sha: 901990d6be3e96f2a2cf91d2f38b93989e49f0f6
doc_id: 1007689
cord_uid: vjwglx9f

Coronavirus disease 2019 (COVID-19) has been recognized as a global pandemic outbreak, opening the most severe socio-economic crisis since World War II. Different scientific activities have been emerged in this global scenario, including the development of innovative analytical tools to measure nucleic acid, antibodies, and antigens in the nasopharyngeal swab, serum, and saliva for prompt identification of COVID-19 patients and to evaluate the immune response to the vaccine. The detection of SARS-CoV-2 in saliva remains a challenge for the lack of sufficient sensitivity. To address this issue, we developed a novel paper-based immunoassay using magnetic beads to support the immunological chain and 96-well wax-printed paper plate as a platform for color visualization by using a smartphone combined with Spotxel free-charge app. To assess the reliability of the measurement of SARS-CoV-2 in saliva, untreated saliva was used as a specimen and the calibration curve demonstrated a dynamic range up to 10 μg/mL, with a detection limit equal to 0.1 μg/mL. The effectiveness of this sustainable analytical tool in saliva was evaluated by comparing the data with the nasopharyngeal swab specimens sampled by the same patients and tested with Real-Time PCR reference method, founding 100% of agreement, even in the case of high Cycle Threshold (CT) numbers (low viral load). Furthermore, the positive saliva samples were characterized by the next-generation sequencing method, demonstrating the capability to detect the Delta variant, which is actually (July 2021) the most relevant variant of interest.

European Centre for Disease and Centre for Disease Control and Prevention (https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html) have highlighted the emerging circulation of genetic variants of SARS-CoV-2 around the world throughout the COVID-19

pandemic. They established a variant classification scheme that includes the variant of concern, the variant of interest, and the variant under monitoring. For the variant of concern, there is clear evidence of a significant impact on transmissibility, severity, and/or immunity that is likely to have an impact on the epidemiological situation, while the variant of interest could imply a significant impact on transmissibility, severity, and/or immunity, realistically having an impact on the epidemiological situation. Variants under monitoring are the additional variants of SARS-CoV-2 detected as signals through epidemic intelligence, rules-based genomic variant screening, or preliminary scientific evidence, and they could have properties similar to those of a variant of concern although the evidence is weak or has not yet been assessed. WHO proposed labels by using letters of the Greek alphabet for global SARS-CoV-2 variants of concern and variants of interest to be used alongside the scientific nomenclature in communications about variants to the public (https://www.who.int/news/item/31-05-2021-who-announces-simple-easy-to-say-labels-for-sarscov-2-variants-of-interest-and-concern). In this period (July 2021), the Delta variant is the one that is quickly spreading, triggering a new phase in COVID-19. For instance, the Centers for Disease Control and Prevention declared Delta as a variant of concern on 15 June in the United States, being its prevalence estimated at least at 14%, while in the United Kingdom Delta variant was found in more than 90% of all infections (Kupferschmidt and Wadman, 2021) . Despite the vaccination campaign, it seems that COVID-19 will continue to be part of our lives for many years to come. Recently (April 2021) the CEO of Pfizer Albert Bourla reported that people may need to get vaccinated against the J o u r n a l P r e -p r o o f coronavirus annually (https://www.cnbc.com/2021/04/15/pfizer-ceo-says-third-covid-vaccine-doselikely-needed-within-12-months.html). This means that testing for antigens and antibodies will continue to be of vital importance to ensure that we remain fully protected. For reliable evaluation of infectious people, the antibody test is not recommended because antibodies are produced by human beings in 7-15 days after the exposure to the virus, thus it is not suitable for identifying the infected people in a timely fashion as well as for an early diagnosis of COVID-19 (Ma et al., 2020; Mekonnen et al., 2021) . For RNA detection several analytical devices have been developed Zhu et al., 2020) , including the use of CRISPR-Technology (Ning et al., 2021) , which is a vanguard technology as demonstrated by the Nobel Prize in Chemistry 2020 to Emmanuelle

Charpentier and Jennifer A. Doudna, having discovered the CRISPR/Cas9 genetic scissor (https://www.nobelprize.org/prizes/chemistry/2020/press-release/). In the case of antigen detection (Fabiani et al., 2021a) , the immunosensors developed are based on the detection of i) nucleocapsid (N) protein, which is the protein responsible for genome packaging (Masters, 2019; Laude and Masters 1995) ; ii) Spike (S) protein, which is the protein present of the surface of the SARS-CoV-2 virus with affinity with the human angiotensin-converting enzyme 2 (hACE2), exploited to infect human cells (Verdecchia et al., 2020; Ward et al., 2020; Xia et al.,2020) . In detail, the S protein of SARS-CoV-2 is composed of two subunits, S1 and S2, where the S1 subunit contains a receptorbinding domain that recognizes and binds the host receptor, while the S2 subunit umpires the viral cell membrane fusion (Huang et al., 2020) . Among N, S1, and S2, the S1 subunit is less conserved and more highly specific to SARS-CoV-2, thus its detection could improve the selectivity of the analytical system (Ward et al., 2020) . For S protein detection, the first immunosensor was reported by Seo et al., which developed a field-effect transistor device for detecting SARS-CoV-2 in nasopharyngeal swab specimens by using antibody for the S protein immobilized on the graphene sheets coating the fieldeffect transistor (Seo et al., 2020) . This sensor was able to detect S protein and SARS-CoV-2 with a J o u r n a l P r e -p r o o f detection limit of 100 fg/mL and 1.6 × 10 1 PFU/mL, respectively for COVID-19 patients and cultured viruses. Even if the nasopharyngeal swab specimen is one of the most used sample tested in the biosensing field (Shao et al., 2021; Kimet al., 2021 , Raziq et al., 2021 , this sampling requires an invasive procedure and skilled personnel, hampering the accurate analysis with sampling carried out by the end-users. Another useful specimen is saliva because saliva has the advantage of non-invasive sampling and delivers accurate data, avoiding the variability of nasopharyngeal specimens due to the complex sampling (Wyllie et al. 2020) . To this regard, we developed the first immunosensing system for the S and N proteins in saliva by exploiting magnetic beads (MBs) as support of the immunological chain as well as for a sensitive sampling of target analyte in saliva, and nano-modified screen-printed electrodes combined with a portable instrument for the measurement, obtaining a detection limit equal to 19 ng/mL and 8 ng/mL in untreated saliva, respectively for S and N protein (Fabiani et al., 2021b) . The suitability and advantages of saliva for SARS-CoV-2 detection by smart biosensors were successively reported in the literature by other relevant groups (Hall's, Kelley's, and Gao's groups) (Singh et al., 2021; Yousefy et al., 2021; Torrente-Rodriguez et al., 2020) .

In the era of sustainability, the use of paper-based devices and smartphone-assisted biosensors has established one of the main pillars in the diagnostics field. The use of paper in their design allows for:

i) the fabrication of the plastic-free devices; ii) the loading of the reagents onto the cellulose network delivering a reagent-free measure; iii) the customization of microfluidics with an equipment-free system exploiting the capillarity of the paper; iv) a treatment-free measurement thanks to the filter paper which can treat the sample during the analysis, v) the possibility to be incinerated, rendering more sustainable the management of waste in the case of infected samples (Cate et al., 2015; Hamedi et al., 2016; Caratelli et al., 2020; Grant et al., 2020; Antiochia, 2021 , Zhu et al., 2021 , Noviana et al., 2021 . At the same level, smartphone-assisted devices can boost the acquisition of the signal by smartphone, avoiding the use of a dedicated instrument. Furthermore, an easy J o u r n a l P r e -p r o o f management is carried out by using a dedicated app or Internet of Things (Roda et al., 2016) . For the antigen detection, to our knowledge, the first paper-based device is the one developed in 2021 by Yakoh et al. (Yakoh et al., 2021) . In detail, they developed a paper-based electrochemical platform as a screening tool to detect SARS-CoV-2 immunoglobulins (represented by IgG and IgM) as well as S protein using a portable potentiostat (Emstat3 Blue wireless potentiostat). In the case of S protein, the antibody was immobilized onto the paper-based working electrode surface and the presence of obtaining a dynamic range comprised between 1-1000 ng/mL with a detection limit of 0.11 ng/mL.

Herein, we report a novel immunoassay based on:

i) the use of MBs as support for the immunological chain and for an easy way for preconcentration;

ii) a 96-well wax-printed paper-based plate as a platform to load MBs and to contain the reagent for colorimetric detection without the addition of enzymatic substrate;

iii) the smartphone combined with Spotxel free-charge app for an equipment-free and accurate evaluation of colored signal.

The suitability of the paper-based platform was evaluated by testing S protein in standard solutions and in saliva samples of COVID-19 patients affected also by Delta variant, demonstrating the ability to identify the infectious patients at low viral load, e.g. Cycle Threshold (CT) values higher than 30 in RT-PCR measures, overcoming the drawbacks of the commercial available immunochromatographic antigen kit able to identify only patients with high viral load.

J o u r n a l P r e -p r o o f

The target SARS-CoV Spike (subunit S1) protein (0.5 mg/mL), monoclonal antibody anti-SARS-CoV-2 (produced in mouse, 1 mg/mL), SARS-CoV-2 Spike antibody-HRP Chimeric MAb (MAb-HRP, 100 g),

were purchased from Sinobiological (Germany). The target SARS Coronavirus 2019 Spike

Recombinant protein 100 g from Sinobiological (Germany), the bovine serum albumin (BSA) was used as blocking agent for covered magnetic beads to reduce the aspecific adsorptions, Tween 20, sodium azide, and all other reagents were obtained from Sigma (USA). Dynabeads® Pan Mouse IgG pre-coated with anti-Mouse IgG able to bind monoclonal antibody (supplied as a suspension

containing 4 x 10 8 beads/mL in phosphate buffered saline, pH 7.4) was from Life Technologies (USA).

A rotary shaker and a magnetic rack/particle concentrator were from Dynal Biotech (USA Sciences, University of Padova. Micrographs of the 96-well paper platform before and after the addition of MBs were acquired through electron microscopy FEI Quanta 400. The monitoring of the colorimetric response was carried out using a Huawei smartphone assisted with Spotxel free-charge app. This app is able to process colorimetric data. It is important to acquire the image of the plate by photographing it, respecting the guide wells drawn in the app. Once the image has been captured, the app starts processing the data and provides numeric values.

The 96-well paper-based platform was designed using a drawing software (Adobe Illustrator). We designed the 96-well paper-based platform with a 7 mm-diameter well, being the same diameter as the conventional ELISA plate. Successively, the designed template was printed onto filter paper (67 g/m 2 , Cordenons, Italy) with a solid-ink printer (ColorQube 8580, Xerox, USA). The 96-well paperbased platform was then cured in an oven for 2 min at 100 °C. For delivering a reagent-free 96-well paper-based platform, each well was loaded with 10 µL of TMB to ask the end-user only the addition of MBs. The pre-loaded 96-well wax-printed paper-based platform stored under vacuum at room temperature was stable up to 10 days, after 15 days a decrease of response was observed.

The MBs-based assay involves sequential procedures: 4. incubation for 30 min at RT; 5. washing by adding 1 mL of PBS + 0.05% Tween 20 into the tube containing the MBs, followed by shaking and inserting the magnet to concentrate the MBs. After, the supernatant was discarded and the procedure was repeated twice to eliminate the excess of unreacted labeled antibodies;

6. resuspension of the MBs in 100 L of PBS;

7. for the measurement, 10 μL of this suspension (three replicates for each sample) were cast onto the wells of the printed plate, preloaded with 10 μL TMB, and the colorimetric response was revealed using Huawei smartphone-assisted with Spotxel free-charge app.

In this immunoassay procedure, the classical sequential incubations for the immuno-recognition events are merged in a single incubation of 30 min, for delivering an easy-to-use device. 

3.1 Description and characterization of immunoassay based on the use of MBs, 96-well wax-printed paper plate, and smartphone

The use of paper for the development of cost-effective and easy-to-use diagnostic devices for low resource conditions has been boosted in the last years for the diagnosis of diseases. COVID-19

outbreak has further enlarged their application due to the unravel features of paper-based devices including multiplexing capabilities, high sensitivity, high selectivity, easiness to use, costeffectiveness, mass manufacturing, rapidity, and single-use, all characteristics that match the ones highlighted in the case of an ideal device for effective use in pandemics (Bhalla et al., 2020) .

Herein, we have chosen to configure our sustainable platform by exploiting:

i) the use of a 96-well wax-printed paper plate to perform 96 simultaneous measurements to deliver a multiplexing analysis;

ii) MBs as support of the immunological chain, being able to load a high number of antibodies thanks to the high surface/volume ratio as well as the capability of MBs to preconcentrate the virus with the final result of improved sensitivity;

iii) the use of monoclonal antibodies for their ability to recognize only one epitope as well as the selection of S protein as target analyte being the specific protein of only SARS-CoV-2, allowing for an analytical tool with high selectivity; iv) the exploitation of porosity of paper in 96-well wax-printed paper to load the enzymatic substrate. In addition, each well is able to work as a sensing element and as a reagent reservoir for rendering the analysis easy to perform. Moreover, the selection of saliva as a specimen does not require a health worker for the sampling; MBs are present both on the fiber as well on the space between the fibers, allowing for a visible homogeneous blue color due to the formation of the enzymatic by-product, as reported in Figure 3 .

In addition, we estimated the dimension of MBs (inset reported in Figure 2D ) equal to ca. 4 µm, which is a value in agreement with the one provided by the manufacturer (4.5 ± 0.5 µm). The presence of MBs was also confirmed by EDX, indeed the microanalysis confirmed the presence of Fe on the paper surface when MBs were added ( Figure 2D ) when compared with the EDX analysis using paper without the addition of MBs ( Figure 2B ). One of the strategies to reduce the background in the immunoassay is the use of non-ionic detergents such as Tween 20 and Triton X-100 for washing steps, to avoid the aspecific adsorption (Steinitz, 2000) . In the case of the immunoassay using MBs, the function of Tween 20 is not only the improvement of the washing step due to the different surface tension of the water-based solution with Tween 20, but also to interact with the surface of MBs for hindering the adsorption of the untargeted analyte. In our previous work (Fabiani et al., 2021b) , we developed MBs-based immunoassay for SARS-CoV-2 detection with electrochemical transduction and alkaline phosphatase as immunological chain label, using Tween 20 at the concentration of 0.05% (w/v) as an additional reagent of buffer during the washing step. For improving sensitivity in the case of colorimetric detection, we have selected HRP as label enzyme, because the detection of blue color on paper gives a more sensitive measure in respect to yellow color (the color produced by the use of naphthyl phosphate as enzymatic substrate combined with alkaline phosphate as label enzyme). In the case of 96-well wax-printed paper-based plate, we investigated the suitability of HRP as a label, observing a high background signal (data not shown) due to the aspecific adsorption between MBs and HRP enzyme. To overcome this issue, we use Tween 20 0.05 % (w/v) not only for the washing step (as in our previous work) but also as additive in the PBS buffer during the incubation step to avoid the aspecific adsorption. Because it is reported in the literature that non-ionic detergents have effects on the antigen (Hoffman and Jump, 1986) , hampering the formation of immune complexes, we 

As reported in Figure 3 no variation in the plaque forming has been observed when SARS-CoV-2 has been incubated with Tween 20, confirming any inactivation under our working condition, in agreement also with the literature (Patterson et al., 2020) . Thus, we used Tween 20 as a reagent during the incubation step without any effect on the immunocomplex formation and on the immunoassay sensitivity. 3.3 Suitability of the reagent-free approach using the 96-well wax-printed paper plate

With the final aim to deliver an easy-to-use device, we exploited the porosity of the paper to load the enzymatic substrate (TMB) in the well. In detail, we evaluated the response of the conceived paperbased immunoassay both i) when TMB was directly added in the well together with MAb-HRP or ii)

when TMB was previously loaded onto the well and waited to dry for a reagent-free assay.

As depicted in Figure 4 A, we observed that in the case of the simultaneous addition of both HRPlabelled antibody and TMB, a typical sigmoidal behavior was observed with a dynamic range of MAb-HRP from 0.0001 to 1 ng/mL. Otherwise, in the case of reagent-free approach a decrease of sensitivity J o u r n a l P r e -p r o o f was observed, due to the diffusion which is different when the reaction happens in drop or in the cellulose network. However, even if less sensitive, the reagent-free system allows for a useful detection of SARS-CoV-2, thanks to the high sensitivity of the system based on MBs used in the immunoassay.

The paper-based ELISA using MBs was developed by using Dynabeads Pan Mouse IgG precoated with

Anti-mouse IgG able to favor the correct orientation of the MAb Anti-S, improving the sensitivity of the system. The amount of MBs is a crucial parameter for highly sensitive detection, providing the best highest signal-to-noise ratio. We selected the amount of MBs employed by testing 5, 10, and 20

µL at a concentration of 4 × 10 8 beads/mL, added to a volume of 500 µL with a final concentration of 4 × 10 6 , 8 × 10 6 , 1.6 × 10 7 beads/mL, respectively. As shed light in Figure 4B , the highest signal difference of the immunoassay in the absence and in the presence of 1 µg/mL of S protein was observed for 10 µL, being this value also in agreement with the value selected in our previous work (Fabiani et al., 2021b) .

In this work, for the immunological chain, µg/mL to 10 µg/mL were tested in standard solution ( Figure 4D , left) obtaining a linear behavior described by the following equation y = (9.22 ± 0.03) + (2.63 ± 0.03) x, R 2 = 0.999, with a detection limit equal to 0.01 µg/mL, calculated as blank signal + 3 standard deviation (SD). The matrix effect in the case of saliva specimen was evaluated by constructing the calibration curve in untreated saliva ( Figure 4D , right), observing a low matrix effect. Indeed, the calibration curve in saliva was described by the following equation: y = (5.62 ± 0.13) + (2.79± 0.15) x, R 2 = 0.991, with a detection limit equal to 0.1 µg/mL. The repeatability was assessed at the concentration of 0.6 µg/mL for saliva (n=3) observing an RSD% equal to 9.5 %.

J o u r n a l P r e -p r o o f + 300 µL of sample tested (negative control or 1 µg/mL S protein; C) Study of MAb-HRP concentration. 10 µL of MBs, 200 µL of MAb-HRP anti SARS-CoV-2, 1, 2, and 4 µg/mL (in PBS + 0.05% Tween 20) + 300 µL of sample tested (negative control or 1 µg/mL S protein; D) Calibration images obtained using the chosen parameters for S protein detection in buffer and in untreated saliva. The mean value (n = 3) with the corresponding standard deviation and the image of paper plate were reported for each measurement.

To assess the selectivity of the proposed 96-well wax-printed paper platform, a specificity test was performed analyzing:

i) pandemic influenza A virus (pH1N1) (7 × 10 4 PFU/mL); ii) N protein (2 µg/mL), another target protein used for SARS-CoV-2 quantification iii) Legionella pneumophila (10 4 CFU/mL), bacteria that is transmitted by aerosol as in the case of SARS-CoV-2, being able to survive in this matrix for several months giving pneumonia disease iv) Botulinum toxin C (10 -8 M), a toxin that can also be subjected to airborne transmission.

As reported in Figure 5A , the signal obtained for seasonal influenza virus A, N protein, Legionella pneumophila, and Botulinum toxin C gave a signal comparable to the blank signal, demonstrating the absence of the interference.

To assess the effectiveness of 96-well wax-printed paper platform using clinical samples, saliva and nasopharyngeal swabs were tested using paper-based device and one-step Real-Time RT-PCR, respectively. In detail, we tested saliva samples using fresh samples because in the case of freezed samples we observed in our previous work a reduction of signal (Fabiani et al., 2021b) . In detail, we used fresh saliva sampled after drinking a glass of water, with the aim of an easy sampling without any treatment, to match the requirement of a point of care system. As depicted in Figure 5B , we observed a well-established difference in the case of positive and negative samples, and we selected the arbitrary value of 3 as the cut-off value, considering the variability of the different saliva samples.

The agreement was obtained in 12/12 samples (Table S1) Figure 5 . A) Specificity test with pandemic influenza A virus (pH1N1) (7 × 10 4 PFU/mL) (▀), N protein of SARS-CoV-2, 2 µg/mL (▀), Legionella pneumophila 10 4 CFU/mL (▀), Botulinum toxin C 10 -8 M (▀),S protein of SARS-CoV-2 1 µg/mL (▀); B) Six negative(▀ ▀ ▀ ▀ ▀ ▀) and six positive (▀ ▀ ▀ ▀ ▀ ▀) clinical samples analyzed using 96-well wax-printed paper platform and confirmed by RT-PCR. The mean value (n = 3) with the corresponding standard deviation and the image of paper plate were reported for each measurement; C) Genomic comparison of SARS-CoV2 variants analyzed in this study vs reference strain isolated in Wuhan, China (Genbank acc. n. NC_045512.2).

Line markers represent nucleotide mutations: A (▀ ), C (▀ ), G (▀ ), T (▀ ), N (▀) and deletion (▀).

Herein, we reported a novel paper-based device for an easy, accurate, and fast detection of SARS-

CoV-2 detection in saliva specimens using a smartphone as a reader (Table S2 ). The sensing scheme relies on the construction of the immunological chain onto magnetic beads in an untreated saliva sample in 30 min; after the washing steps, the magnetic beads are loaded onto the paper-based wells containing the enzymatic substrate, giving a colorimetric signal in the presence of SARS-CoV-2. The use of a smartphone, combined with Spotxel free-charge app, allowed for colorimetric detection, overcoming the limitation of eye-naked visualization, in which the sensitivity of the operator can affect the analysis. Furthermore, the use of paper allows for quantifying the target analyte by the only addition of the magnetic beads suspension onto the wells, because the enzymatic substrate has been already loaded on the cellulose network. In addition, the use of 96-wells wax-printed paper is able for the multiplexing analyses, boosting the rapid response and easy management of multiple samples. The specimens of patients analyzed, saliva using the immunoassay and nasopharyngeal swab using RT-PCR, demonstrated the agreement of the results obtained with the advantages in terms of time analysis (30 minutes vs 3 hours) and cost (ca. € 3 vs € 20). The possibility to test the samples with the next-generation sequencing method demonstrated the capability to detect also the Delta variant. Therefore, this novel paper-based assay provides a new family of paper-based devices, characterized by an equipment-free approach, boosting the application of this type of paper-based smart analytical tools for multiplexing analysis also in limited resources countries.

The Coronavirus Nucleocapsid Protein

TrAC Trend